K
Katarzyna Futrega
Researcher at Queensland University of Technology
Publications - 6
Citations - 135
Katarzyna Futrega is an academic researcher from Queensland University of Technology. The author has contributed to research in topics: Population & Stromal cell. The author has an hindex of 4, co-authored 6 publications receiving 94 citations. Previous affiliations of Katarzyna Futrega include Translational Research Institute.
Papers
More filters
Journal ArticleDOI
The Microwell-mesh: A high-throughput 3D prostate cancer spheroid and drug-testing platform.
Eman Mohamed Othman Mosaad,Eman Mohamed Othman Mosaad,Karen F. Chambers,Katarzyna Futrega,Judith A. Clements,Michael R. Doran +5 more
TL;DR: The results demonstrate that 3D micro-tumours, unlike 2D monolayers, are not hypersensitive to Docetaxel or Abiraterone Acetate, providing a superior platform for the evaluation of sequential drug treatment.
Journal ArticleDOI
Sheep as a model for evaluating mesenchymal stem/stromal cell (MSC)-based chondral defect repair
TL;DR: In this article, the mesenchymal stem/stromal cells (MSC) were used to study articular cartilage repair in a large animal model, including sheep.
Journal ArticleDOI
Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures.
Eman Mohamed Othman Mosaad,Eman Mohamed Othman Mosaad,Eman Mohamed Othman Mosaad,Karen F. Chambers,Katarzyna Futrega,Katarzyna Futrega,Judith A. Clements,Michael R. Doran +7 more
TL;DR: Stromal cell composition and geometry influences PCa cell migration, growth and drug response, and the Microwell-mesh and microtissues are powerful tools to study these complex 3D interactions.
Journal ArticleDOI
HIF-1α-stabilizing agent FG-4497 rescues human CD34+ cell mobilization in response to G-CSF in immunodeficient mice
Bianca Nowlan,Katarzyna Futrega,Marion E. G. Brunck,Gail Walkinshaw,Lee E. Flippin,Michael R. Doran,Michael R. Doran,Michael R. Doran,Jean-Pierre Levesque +8 more
TL;DR: Results suggest that the PHD inhibitor FG-4497 also increases human HSPC mobilization in a xenograft mouse model, suggesting the possibility of testing PHD inhibitors to boost HSPCs mobilization in response to G-CSF in humans.
Journal ArticleDOI
Constraints to counting bioluminescence producing cells by a commonly used transgene promoter and its implications for experimental design.
Eman Mohamed Othman Mosaad,Eman Mohamed Othman Mosaad,Eman Mohamed Othman Mosaad,Katarzyna Futrega,Inge Seim,Inge Seim,Inge Seim,Brian S. Gloss,Karen F. Chambers,Judith A. Clements,Michael R. Doran +10 more
TL;DR: It is shown that it is possible to generate a range of stable and reliable luciferase reporter prostate- and breast- cancer cell populations but advise not to assume stability across different culture conditions.